Cargando…
87 Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
BACKGROUND: Patients with Idiopathic nonhistaminergic angioedema appear to have similar clinical features and pathogenesis as those with hereditary angioedema. Icatibant, a selective bradykinin β2 receptor antagonist, licensed for use in acute attacks of hereditary angioedema could be also effective...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization Journal
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512802/ http://dx.doi.org/10.1097/01.WOX.0000411832.77376.7d |